Nesher Pharma gets USFDA final approval for Dextroamphetamine sulfate extended-release capsules
News Neshar Pharmaceuticals, a subsidiary of Zydus Pharmaceuticals USA has received final approval from the USFDA to market Dextroamphetamine Sulfate exten...
Comments